Clearmind Medicine Says Recently Signed A Non-binding Term Sheet With Dr Glitter Pty Ltd For Mutual Development In ActivCrystal Format
Clearmind Medicine Says Recently Signed A Non-binding Term Sheet With Dr Glitter Pty Ltd For Mutual Development In ActivCrystal Format
Clearmind Medicine表示最近與Dr Glitter Pty Ltd簽署了一份非約束性條款清單，以共同開發ActivCrystal格式。
The two companies plan to collaborate on the development and commercialization of Clearmind's proprietary MEAI-based alcohol substitute and Dr Glitter Pty Ltd's proprietary ActivCrystal technology. The term sheet outlines preliminary terms that, upon the mutual agreement of the parties, will be memorialized in a definitive agreement that sets forth a framework for advancing Clearmind and Dr Glitter Pty Ltd's groundbreaking innovations.
兩家公司計劃合作開發和商業化Clearmind專有的基於MEAI的酒精替代品和Dr Glitter Pty Ltd的專有ActivCrystal技術。條款表概述了初步條款，經雙方同意，這些條款將在最終協議中予以紀念，該協議規定了推進Clearmind和Dr Glitter Pty Ltd突破性創新的框架。